Session Tracks

Conference session tracks

The ICPLDRPS features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Health Care Law. Each track gives researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain.

This conference contributes to global sustainability by aligning its research discussions and academic sessions with the United Nations Sustainable Development Goals, fostering knowledge exchange, innovation and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 10
SDG 10 Reduced Inequalities
SDG 16
SDG 16 Peace, Justice and Strong Institutions
01
Track

Pharmaceutical Law Fundamentals

This track will explore the foundational principles of pharmaceutical law, including the legal frameworks governing drug development and approval processes. Participants will gain insights into the interplay between law and the pharmaceutical industry.

02
Track

Regulatory Oversight in Drug Approval

This session will focus on the role of regulatory agencies in the drug approval process, examining the standards and guidelines that govern pharmaceutical products. Discussions will include the impact of regulatory decisions on public health and safety.

03
Track

Ethical Considerations in Clinical Trials

This track will address the ethical dilemmas faced during clinical trials, including informed consent and participant safety. Experts will discuss the balance between scientific advancement and ethical responsibility.

04
Track

Medication Compliance and Patient Safety

This session will investigate the legal implications of medication compliance and its impact on patient safety. Participants will explore strategies to enhance adherence to prescribed therapies while minimizing legal risks.

05
Track

Pharmacovigilance and Risk Management

This track will delve into the legal frameworks surrounding pharmacovigilance and the importance of monitoring drug safety post-approval. Discussions will highlight the responsibilities of pharmaceutical companies in managing risks associated with their products.

06
Track

Prescription Law and Patient Rights

This session will examine the legal aspects of prescription law, focusing on patient rights and the responsibilities of healthcare providers. Participants will analyze case studies that highlight the intersection of law and patient care.

07
Track

Drug Liability and Legal Accountability

This track will explore the legal liabilities associated with pharmaceutical products, including issues of negligence and product liability. Legal experts will discuss landmark cases and their implications for the industry.

08
Track

Health Policy and Pharmaceutical Governance

This session will focus on the intersection of health policy and pharmaceutical governance, examining how laws shape drug access and affordability. Participants will engage in discussions about policy reforms and their potential impact on public health.

09
Track

FDA Compliance and Regulatory Challenges

This track will address the complexities of FDA compliance, including the challenges faced by pharmaceutical companies in meeting regulatory requirements. Experts will provide insights into best practices for navigating the regulatory landscape.

10
Track

Safety Standards and Quality Assurance

This session will explore the legal standards for safety and quality assurance in pharmaceutical manufacturing. Participants will discuss the implications of non-compliance and the role of law in ensuring product safety.

11
Track

Emerging Trends in Health Care Law

This track will examine the latest developments in health care law as they pertain to the pharmaceutical industry. Discussions will include the impact of technological advancements and evolving legal frameworks on drug regulation.